The burden of coronary, cerebrovascular and peripheral arterial disease

Area of Science:

• Cardiovascular Medicine
• Epidemiology
• Health Economics

Background:

• Atherothrombosis is a generalized vascular disease affecting coronary, cerebral, and peripheral arteries.
• It manifests as myocardial infarction, ischemic stroke, and peripheral arterial disease, posing a significant global health burden.
• Increasing longevity contributes to a rising prevalence of atherothrombotic diseases, particularly in older populations.

Purpose of the Study:

• To highlight the substantial clinical and economic impact of atherothrombosis.
• To emphasize the need for effective interventions to reduce mortality and morbidity associated with atherothrombosis.
• To advocate for evidence-based strategies for targeted treatment of patients at high risk.

Main Methods:

• Review of epidemiological data on atherothrombosis prevalence and mortality.
• Analysis of economic burden, including healthcare spending in the United States.
• Discussion of clinical outcomes and prognosis associated with atherothrombotic events.

Main Results:

• Atherothrombosis accounts for at least 22% of global deaths annually.
• Stroke, a key manifestation, is a leading cause of disability and death in industrialized nations.
• The disease significantly reduces life expectancy and incurs over $300 billion in annual healthcare costs in the US.

Conclusions:

• There is an urgent need for effective interventions to mitigate the impact of atherothrombosis.
• Evidence-based medicine, incorporating economics, clinical trials, and risk stratification, is essential for optimal treatment.
• Targeted interventions are necessary to reduce the growing burden of this widespread vascular disease.